Most Recent Articles by Shannon Aymes, MD
Rectal diazepam is currently the only FDA-approved treatment for pediatric status epilepticus.
The migraines were not likely associated with acute altitude syndrome, as the participants were conditioned to living in the low-oxygen environment.
While several studies have demonstrated efficacy in refractory epilepsy, it is still not clear how cannabidiol may have an impact on current epilepsy treatments.
There are a limited number of prediction models that identify patients at risk of major bleeding after stroke or TIA.
Most prescriptions for long-term opioid therapy were written by internal or family medicine physicians.
More Articles by Shannon Aymes, MD
Neurology Advisor Articles
- 5 Key Findings Presented at 2018 Parkinson Disease Conference
- Parkinson Disease and the Gut: Treatment Potential Abounds
- Managing Comorbid Migraine and Mood Disorders: A Synergistic Approach
- Stroke-Code Patients With Low NIHSS Score, No Acute Imaging Findings Often Misdiagnosed
- Ethical Challenges of Nusinersen: Considerations When Counseling on Treatment
- Gender and Multiple Sclerosis: How It Influences Prognosis and Future Treatment
- Drug Prices Increase More Than Expected After Shortages
- Potentially Inappropriate Opioid Prescribing Tied to Overdose
- Loss of Function Variants in LRKK1 and LRKK2 Not Linked to Parkinson Disease
- Scribes Improve Physician Workflow, Patient Interaction